Why the study?
Intense physical activity causes physiological adaptations but can trigger adverse events like sudden cardiac arrest, prompting the assessment of combined CPET and cardiac biomarkers in young professional athletes.
Do variations in cardiac biomarkers correlate with cardiopulmonary exercise testing parameters in young professional football players?
Do variations in cardiac biomarkers correlate with cardiopulmonary exercise testing parameters in young professional football players?
Combined CPET and biomarker assessment in young athletes shows that while cTnI and NT-proBNP remain undetectable, Myo, CK-MB, and D-dimers correlate with exercise parameters, suggesting potential utility in sports cardiology evaluations.
May support combined CPET-biomarker assessment in young athletes; leaves open validation in larger prospective cohorts.
Constant and intense physical activity causes physiological adaptive changes in the human body, but it can also become a trigger for adverse events, such as sudden cardiac arrest or sudden cardiac death. Our main objective was to assess the use of combined cardiopulmonary exercise testing (CPET) and cardiac biomarker determinants in young professional athletes. We conducted a study which involved the full examination of 19 football players, all male, aged between 18 and 20 years old. They underwent standard clinical and paraclinical evaluation, a 12-lead electrocardiogram (ECG), and transthoracic echocardiography (TTE). Afterwards, a tailored CPET was performed and peripheral venous blood samples were taken before and 3 h after the test in order to determine five biomarker levels at rest and post-effort. The measured biomarkers were cardiac troponin I (cTnI), myoglobin (Myo), the MB isoenzyme of creatine-kinase (CK-MB), the N-terminal prohormone of brain natriuretic peptide (NT-proBNP) and D-dimers. While cTnI and NT-proBNP levels were undetectable both at rest and post-effort in all subjects, the variations in Myo, CK-MB and D-dimers showed significant correlations with CPET parameters. This highlights the potential use of combined CPET and biomarker determinants to evaluate professional athletes, and encourages further research on larger study groups.
No takes yet. Share an insight, caveat, or question.
Costache et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: